Cite
HARVARD Citation
Sellam, J. et al. (n.d.). CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis. Arthritis and rheumatism. 65 (9), pp. 2253-2261. [Online].